Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenobamate as Adjunctive Therapy in Partial Onset Seizures
NCT01866111Phase 2Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Jul 2013
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of cenobamate in focal onset seizure, sponsored by SK Life Science, Inc.. Started Jul 2013; status: completed.
02
Drugs
cenobamate
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT01866111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866111.